Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer

Individuals who are immunocompromised (IC) due to therapy or underlying disease are at increased risk of herpes zoster (HZ). This study evaluates the public health impact of recombinant zoster vaccine (RZV) relative to no HZ vaccination for the prevention of HZ among adults aged ≥18 years diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales: Curran, Desmond, Patterson, Brandon J., Carrico, Justin, Salem, Ahmed, La, Elizabeth M., Lorenc, Stéphane, Hicks, Katherine A., Poston, Sara, Carpenter, Christopher F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Zoster
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038038/
https://www.ncbi.nlm.nih.gov/pubmed/36880669
http://dx.doi.org/10.1080/21645515.2023.2167907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038038/
https://www.ncbi.nlm.nih.gov/pubmed/36880669
http://dx.doi.org/10.1080/21645515.2023.2167907

Ejemplares similares